Inservice education prepared pharmacists for discussions with physicians about opioid analgesics. Phase 3 centered on an automatic interchange from meperidine to an equianalgesic dose of morphine ...
DELRAY BEACH, FL / ACCESSWIRE / September 24, 2024 / Adolore BioTherapeutics, Inc., ("Adolore" or the "Company"), a biotechnology company developing transformational opioid-free intracellularly-delive ...
despite minimal evidence that opioids are effective as long-term analgesics. With chronic use of opioids, opioid receptors decrease in population, as well as possibly in excitability. This ...
Abuse-deterrent transdermal technology can be used to prevent the misuse of drugs with abuse potential, such as fentanyl, by incorporating aversive agents into transdermal patches. Abuse-deterrent ...